Similarly, the hypothesis posits that increased HS levels accelerate neurodegeneration in AD via increased Aβ and Tau protein aggregation, as well as Aβ plaque formation and hinderance of Aβ fibril and Tau tangle clearance (Liu et al. 2016; Snow et al. 2021). The gene discussed is MAPT; the disease is Alzheimer disease.